To view this email as a web page, click here.

 
Hyaluronic Acid for Knee Osteoarthritis
Intra-articular hyaluronic acid may be suitable as treatment for knee osteoarthritis, a review shows. The findings are inconsistent with many of the cl inical guidelines.
Read more
 
Mechanisms that could Reduce Bone Aging
The potential for intervening in bone loss due to aging may require a broader approach to the interactions of both the hematopoietic and skeletal sys tems.
Read more
 
From Mild to Serious, Common to Rare: The Adverse Events of Osteoporosis Drugs
A market analysis shows that bisphosphonates will reach $14 billion in sales by 2021. As more patients are prescribed these osteoporosis drugs, phy sicians will increasingly be faced with managing drug-related adverse events.
Learn more in this article

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.